MHR
GSK icon

Matthew Hamilton Rosenberg’s GSK GSK Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$112K Hold
2,326
– – 0.02% 335
2026
Q2 		$122K Buy
2,326
+950
+69% +$50.2K 0.02% 320
2026
Q1 		$75.9K Hold
1,376
– – 0.02% 368
2025
Q4 		$67.5K Hold
1,376
– – 0.01% 385
2025
Q3 		$59.4K Hold
1,376
– – 0.01% 398
2025
Q2 		$52.8K Sell
1,376
-189
-12% -$7.22K 0.01% 427
2025
Q1 		$60.6K Sell
1,565
-236
-13% -$8.64K 0.02% 391
2024
Q4 		$60.9K Sell
1,801
-849
-32% -$30.6K 0.02% 390
2024
Q3 		$108K Buy
2,650
+164
+7% +$6.71K 0.03% 309
2024
Q2 		$95.4K Sell
2,486
-164
-6% -$6.9K 0.03% 306
2024
Q1 		$112K Sell
2,650
-4
-0.2% -$165 0.03% 291
2023
Q4 		$98.3K Hold
2,654
– – 0.03% 310
2023
Q3 		$96.2K Hold
2,654
– – 0.03% 289
2023
Q2 		$94.6K Buy
2,654
+212
+9% +$7.6K 0.03% 308
2023
Q1 		$86.9K Sell
2,442
-246
-9% -$8.61K 0.03% 343
2022
Q4 		$94.5K Buy
2,688
+163
+6% +$5.43K 0.03% 317
2022
Q3 		$74K Buy
2,525
+1,401
+125% +$53.1K 0.03% 349
2022
Q2 		$61K Hold
1,124
– – 0.02% 405
2022
Q1 		$61K Hold
1,124
– – 0.02% 412
2021
Q4 		$62K Buy
1,124
+640
+132% +$33.3K 0.02% 381
2021
Q3 		$23K Hold
484
– – 0.01% 494
2021
Q2 		$24K Hold
484
– – 0.01% 456
2021
Q1 		$22K Hold
484
– – 0.01% 435
2020
Q4 		$22K Sell
484
-1,141
-70% -$52.4K 0.01% 417
2020
Q3 		$76K Hold
1,625
– – 0.06% 243
2020
Q2 		$83K Buy
1,625
+98
+6% +$5.03K 0.07% 229
2020
Q1 		$73K Buy
+1,527
New +$81.5K 0.07% 189

Other funds holding GSK

KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return

Matthew Hamilton Rosenberg's GSK Position: Q3 2026 in Review

Matthew Hamilton Rosenberg held its GSK (GSK) position steady in Q3 2026 at 2,326 shares worth $112K. The position accounts for 0.02% of the portfolio, ranked #335.

Matthew Hamilton Rosenberg first reported a position in GSK in Q1 2020 and has held it in 27 quarters since. The position peaked at $122K in Q2 2026. 31 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Matthew Hamilton Rosenberg held 2,326 shares of GSK worth $112K as of Q3 2026.
  • Matthew Hamilton Rosenberg left its GSK share count unchanged in Q3 2026.
  • GSK made up 0.02% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #335 holding.
  • Matthew Hamilton Rosenberg first reported a position in GSK in Q1 2020 and has held it in 27 quarters since.
  • Matthew Hamilton Rosenberg's GSK position peaked at $122K in Q2 2026.
  • 31 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.